Treatment of Candida Urinary Tract Infections
For symptomatic Candida urinary tract infections, oral fluconazole at a dosage of 200 mg (3 mg/kg) daily for 2 weeks is the recommended first-line treatment for fluconazole-susceptible species. 1
Treatment Algorithm Based on Clinical Presentation
Asymptomatic Candiduria
- Treatment is generally not recommended unless the patient belongs to a high-risk group 1, 2
- High-risk groups requiring treatment:
- For patients undergoing urologic procedures:
- Fluconazole 200-400 mg daily OR
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure 1
Symptomatic Candida UTIs
For Candida cystitis (lower UTI):
For Candida pyelonephritis (upper UTI):
For fungus balls:
- Surgical intervention is strongly recommended in non-neonates 1, 2
- Plus systemic antifungal therapy:
- Fluconazole 200-400 mg daily OR
- Amphotericin B deoxycholate 0.5-0.7 mg/kg daily with or without flucytosine 1
- If access to renal collecting system is available, irrigation with Amphotericin B deoxycholate (50 mg/L sterile water) 1, 2
Important Management Considerations
Elimination of Predisposing Factors
- Remove indwelling urinary catheters if present
- Discontinue unnecessary antibiotics
- Address urinary tract obstruction if present 1, 2, 4
- Removing these factors alone resolves candiduria in approximately 50% of cases 2, 5
Antifungal Selection Considerations
- Fluconazole: Achieves high urinary concentrations and is the drug of choice for susceptible species 3, 4, 5
- Amphotericin B deoxycholate: Effective alternative for fluconazole-resistant species, achieving high urinary concentrations 2
- Avoid:
Treatment Duration
- Continue treatment for 2 weeks or until symptoms resolve and urine cultures become negative 1, 2
- Obtain follow-up urine cultures to confirm eradication 2
Common Pitfalls to Avoid
- Treating asymptomatic candiduria unnecessarily in low-risk patients 2
- Failing to remove indwelling catheters or address underlying conditions 2, 5
- Using antifungals with poor urinary concentrations (echinocandins, newer azoles) for uncomplicated UTIs 2, 5
- Using flucytosine as monotherapy due to risk of resistance development 2
- Not distinguishing between colonization and true infection 2, 4
By following this evidence-based approach, clinicians can effectively manage Candida urinary tract infections while avoiding unnecessary treatment in cases of asymptomatic candiduria.